drug

MIND1 System

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Otsuka Pharmaceutical Development & Commercialization, Inc.
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
NCT02219009Phase 2Completed

KOLs & investigators

1
Timothy Peters-Strickland, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Otsuka Pharmaceutical Development & Commercialization, Inc.
company
trial
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
PHASE2
trial
indication
Schizophrenia
indication
Mental Disorder
indication
Treatment Adherence and Compliance
indication
Mental Disorders
indication
KOL
Timothy Peters-Strickland, MD
KOL score —
person